Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)

NCT04571658 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04571658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04571658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Recruiting
Start date
May 2, 2022
Completion date
December 30, 2029
Enrollment
375 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

alport syndrome, focal segmental glomerulosclerosis, fsgs, mcd, mcd - minimal change disease, membranous nephropathy, minimal change disease, minimal change nephrotic syndrome, nephrotic syndrome in children